ANTERIS TECHNOLOGIES LTD 24 July 2020
ASX ANNOUNCEMENT
EXPIRATION OF UNQUOTED OPTIONS
Anteris Technologies Ltd (ASX: AVR) advises that the following unquoted Options have expired:
Unquoted Securities - expired: | ||||
ASX code | Security description | Number | ||
AVRAC | Options expired 21 | July 2020 | Exercisable at $144.00 | 5,350 |
5,350 |
Set out below is an updated capital structure of the Company following the above expired options:
Quoted Securities
ASX code | Security description | Number | |
AVR | Ordinary fully paid shares | 5,910,304 | |
AVRO | Options expiring 18 December 2021 | Exercisable at $8.00 | |
2,370,648 |
Anteris Technologies Ltd
Registered Office:
Suite 302, Level 3 Toowong Tower, 9 Sherwood Road, Toowong QLD 4066
Customer Service:
- 1300 550 310 F: 1300 880 398 International: T: +61 (0)7 3152 3200 F: +61 (0)7 3152 3299
- info@anteristech.com W: anteristech.com
Brisbane •Minneapolis •Geneva •Singapore | ABN 35 088 221 078 |
Updated capital structure of the Company (continued)
Unquoted Securities - on issue following the above expired Options
ASX code | Security description | |
AVRAC | Options expiring 10 December 2020 | Exercisable at $83.00 |
AVRAC | Options expiring 10 December 2020 | Exercisable at $139.00 |
AVRAC | Options expiring 24 June 2021 | Exercisable at $30.00 |
AVRAC | Options expiring 18 November 2021 | Exercisable at $34.00 |
AVRAC | Options expiring 23 March 2022 | Exercisable at $34.00 |
AVRAC | Options expiring 22 September 2022 | Exercisable at $26.00 |
AVRAC | Options expiring 15 December 2022 | Exercisable at $22.00 |
AVRAC | Options expiring 31 December 2027 | Exercisable at $30.00 |
AVRAC | Options expiring 31 December 2027 | Exercisable at $37.00 |
AVRAC | Options expiring 2 April 2028 | Exercisable at $3.60 |
AVRAC | Options expiring 10 April 2028 | Exercisable at $3.60 |
AVRAC | Options expiring 16 May 2028 | Exercisable at $3.60 |
AVRAC | Options expiring 29 May 2028 | Exercisable at $3.60 |
AVRAC | Options expiring 2 June 2028 | Exercisable at $3.60 |
AVRAC | Options expiring 3 January 2029 | Exercisable at $3.60 |
AVRAC | Options expiring 15 May 2029 | Exercisable at $5.90 |
AVRAC | Options expiring 1 September 2029 | Exercisable at $6.80 |
AVRAC | Options expiring 12 July 2029 | Exercisable at $6.80 |
AVRAC | Options expiring 20 March 2025 | Exercisable at $11.20 |
AVRAD | Warrants expiring 18 December 2020 | Exercisable at $79.00 |
AVRAD | Warrants expiring 23 December 2020 | Exercisable at $79.00 |
AVRAD | Warrants expiring 26 October 2024 | Exercisable at $25.00 |
AVRAE | Options expiring 17 April 2025 | Exercisable at $3.50 |
AVRAF | Options expiring 3 June 2025 | Exercisable at $7.58 |
About Anteris Technologies Ltd (ASX: AVR)
Number 4,250 2,000 500 667 1,000 6,750 2,500 3,258 31,737 1,002 1,002 1,500 668 1,254 501 31,890 3,000 4,107 435,000
532,586
52,500
3,800
49,388
105,688
3,750
500
Anteris Technologies Ltd is a structural heart company focused on delivering clinically superior solutions that create life-changing outcomes for patients. Its ADAPT®tissue platform, a next generation technology with zero DNA and zero glutaraldehyde, is the only bioscaffold to demonstrate zero calcification after 10 years of use in complex cardiac surgery. With these advantages, Anteris's best-in-class ADAPT®tissue combined with its valve design has the potential to solve the problems associated with current aortic valve replacement options which are durability and preventing valve degradation.
Authorisation and Additional information
This announcement was authorised by Mr Stephen Denaro, Company Secretary.
For more information:
Ms Kyahn Williamson
WE Communications
- WE-AUAnterisTech@we-worldwide.com
- +61 401 018 828
www.anteristech.com
Twitter: @AnterisTech
Facebook: www.facebook.com/AnterisTech
Attachments
- Original document
- Permalink
Disclaimer
Anteris Technologies Ltd. published this content on 24 July 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 24 July 2020 07:50:09 UTC
